CC-12507

N/A

Report date: 2026/03/13 20:02:36

NME

Base Information

Drug NameCC-12507

Drug Alias NameE2 ligase inhibitorResearch programme: ligase-targeted therapies - CelgeneCC-12507CC-125007

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUbiquitin-protein ligases inhibitors

TargetsUbiquitin-protein ligases

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelgene Corp

China Registration ClassN/A

Active CompaniesCelgene Corp

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A